Boston Scientific
547 hedge funds and large institutions have $36.7B invested in Boston Scientific in 2017 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 43 closing their positions.
5% more capital invested
Capital invested by funds: $34.8B → $36.7B (+$1.87B)
4% more repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 197
0.02% more ownership
Funds ownership: 91.67% → 91.69% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
9% less call options, than puts
Call options by funds: $41.5M | Put options by funds: $45.8M
9% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 43
2% less funds holding
Funds holding: 558 → 547 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$124M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$78.7M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$65M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$59.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$54.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$90.9M |
| 2 |
Jennison Associates
New York
|
-$67.9M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$60.2M |
| 4 |
JP Morgan Chase
New York
|
-$57.1M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$47.9M |
BSX Hedge Fund Activity: Q3 2017 in Review
547 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2017, worth a combined $36.7B — up 5.4% from $34.8B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of BSX and 39 opened new positions — a net loss of 4 holders — while 197 trimmed existing stakes and 205 added.
The largest buyer was Fidelity Investments, adding an estimated $124M. The largest seller was Renaissance Technologies, cutting an estimated $90.9M.
- 547 institutional investors held Boston Scientific (BSX) as of Q3 2017, down from 558 in Q2 2017.
- Funds reported $36.7B of Boston Scientific stock for Q3 2017, up 5.4% quarter-over-quarter.
- 39 funds opened new Boston Scientific positions in Q3 2017 and 43 closed out, a net change of -4 holders.
- The largest Boston Scientific buyer in Q3 2017 was Fidelity Investments, an estimated $124M added.
- The largest Boston Scientific seller in Q3 2017 was Renaissance Technologies, an estimated $90.9M sold.
Based on aggregated 13F filings for Q3 2017.